Contrast agent manufacturer Guerbet is expanding its distribution in Canada through its partnership with Methapharm.
Methapharm will promote and distribute Guerbet products in Canada, further strengthening the companies' four-year business relationship, Guerbet said. The pact is also expected to benefit Guerbet's local production facility in Montreal.
Methapharm will be involved with all Guerbet contrast media products that have regulatory approval in Canada, including Lipiodol, Patent Blue V, OptiRay, Conray, and Telebrix, as well as the injectors OptiStar Elite, OptiVantage, and Illumena Néo.
